Breast Cancer Stage IV Clinical Trials
51 clinical trials for Breast Cancer Stage IV across international registries, including 17 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy — RECRUITING · PHASE2
- A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer — RECRUITING · NA
- A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer — RECRUITING · PHASE1
- HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission — RECRUITING · PHASE2
- A Study of Pembrolizumab and Cryoablation in People With Breast Cancer — RECRUITING · PHASE1
- Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer — RECRUITING · PHASE3
- Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management — RECRUITING · PHASE2
- Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy — RECRUITING · PHASE2
- A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC. — RECRUITING · PHASE1
- SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells — RECRUITING · PHASE1
- HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC — RECRUITING
- Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases — RECRUITING · PHASE2
- RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study — RECRUITING
- Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study — RECRUITING
- A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer — RECRUITING · PHASE1
- HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan — RECRUITING · PHASE2
- Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer — RECRUITING · NA
- Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
- Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients — ACTIVE_NOT_RECRUITING · NA
- Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study — ACTIVE_NOT_RECRUITING
- A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer — COMPLETED · PHASE2
- Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity — ACTIVE_NOT_RECRUITING
- Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib — ACTIVE_NOT_RECRUITING · PHASE2
- A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer — COMPLETED · PHASE1
- Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
- Multicenter Study to Evaluate a Systematized Communication Model for Breast Cancer Patients — COMPLETED · NA
- Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast Cancer — NOT_YET_RECRUITING · PHASE4
- Sitravatinib in Metastatic Breast Cancer — TERMINATED · PHASE2
- RWS of Paclitaxel Liposome Combined With Anti-HER-2 Monoclonal Antibody — OTHER
- A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients. — OTHER · PHASE1
- Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients — OTHER · PHASE1
- Study of Dotatate Imaging in Breast Cancer — OTHER · PHASE2
- PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer — COMPLETED · PHASE1
- Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis — NOT_YET_RECRUITING · PHASE4
- Self-Advocacy Serious Game in Advanced Cancer — COMPLETED · NA
- Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer. — WITHDRAWN · PHASE1
- Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases — COMPLETED · PHASE2
- Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients — OTHER · PHASE3
- A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer — COMPLETED · PHASE1
- BRaziLian outcomE for metAStatic breasT Cancer — OTHER
- A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer — COMPLETED · NA
- RWD Study in HER2+ mBC Patients in Third-Line Therapy — COMPLETED
- Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells — OTHER
- Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study. — OTHER
- Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy — COMPLETED
- The Benefit of Surgery in Stage IV of Breast Cancer — OTHER · NA
- To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors — COMPLETED · PHASE1
- Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer — TERMINATED · PHASE3
- The Resistance and Immune Response to Palbociclib in Breast Cancer — OTHER · NA
- Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients — WITHDRAWN · PHASE2
Refine this search